FindTrial
Sign In

monoclonal antibody therapy

PROCEDURE7 trials

Sponsors

Barbara Ann Karmanos Cancer Institute, MedImmune LLC, National Cancer Institute (NCI), University of Virginia, AIDS Malignancy Consortium

Conditions

AIDS-related LymphomaAdenocarcinoma of the PancreasAdult Non-Hodgkin's LymphomaAnaplastic Large Cell LymphomaLeukemiaLymphomaNHLNon-Hodgkin's Lymphoma

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
WithdrawnNCT00052403
Barbara Ann Karmanos Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific
Start: 2002-02-28Updated: 2014-01-16
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
SuspendedNCT00077493
MedImmune LLCLeukemia, Lymphoma
Start: 2004-01-31End: 2008-10-31Target: 95Updated: 2007-12-28
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
NCT00515892
Cambridge Antibody TechnologyLeukemia, NHL, Non-Hodgkin's Lymphoma
Start: 2007-08-31Target: 50Updated: 2007-08-14

Phase 2

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer
WithdrawnNCT00253526
National Cancer Institute (NCI)Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer +2
Updated: 2015-04-28
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
TerminatedNCT00265928
University of VirginiaLymphoma
Target: 46Updated: 2008-01-28
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
WithdrawnNCT00310128
AIDS Malignancy ConsortiumAdult Non-Hodgkin's Lymphoma, AIDS-related Lymphoma, Anaplastic Large Cell Lymphoma
Start: 2006-02-28Updated: 2016-02-03

Phase 3

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
SuspendedNCT00324831
FavrilleLymphoma
Target: 480Updated: 2013-12-18